Company profile
REMSleep Holdings, Inc.
OTC: RMSL · Healthcare · Medical - Devices
#1118 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
19DFH 9DQ 25GM 31SS 37
v0.1 · 65/100 weight · provisional
↑ listing tenure, growth stability · ↓ return on equity, Piotroski F
Methodology →Revenue TTM
$26.6k
Rev growth YoY (TTM)
-27.1%
Net income (FY)
-$3.0M
Employees
2
as of 2026-08-24
Market cap
$2.5M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$16.7k$16.7k2025
Net income-$3.0M-$3.0M2025
Operating income-$2.8M-$2.8M2025
Total assets$339.8k$339.8k2025
Liabilities$307.7k$307.7k2025
Equity$32.1k$32.1k2025
Revenue trend
FY2014 – FY2025 · USD
FY14
FY14
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is REMSleep Holdings, Inc.’s revenue?
REMSleep Holdings, Inc. booked $16.7k in FY2025 revenue, contracting 86% year over year — slower than 89% of Healthcare companies we track, at a -18062.9% net margin.
Peers · Healthcare
THC Farmaceuticals, Inc.——Sector 10, Inc.——Nanobac Pharmaceuticals, Incorporated——Gemina Laboratories Ltd.——Upper Street Marketing Inc.——Pineapple, Inc.——Neighbors
Hillsborough →Key facts
CEOSanja Pekovic
SectorHealthcare
IndustryMedical - Devices
HeadquartersTampa, FL
ExchangeOTC: RMSL
Employees2
IPO date2009-07-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.